Evidence map›Paper›PMID 32548712›Full record

ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2021

The Prostate Cancer Outcomes (PCO) study in prostate cancer centres certified by the German Cancer Society.

Christoph Kowalski, Günther Carl, Günter Feick, Simone Wesselmann

Abstract read
PubMed Publisher
In one paragraph

Article in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Christoph KowalskiDeutsche Krebsgesellschaft, Kuno-Fischer-Straße 8, 14057, Berlin, Germany. kowalski@krebsgesellschaft.de.
Günther CarlHaus der Krebs-Selbsthilfe - Bundesverband e. V., Thomas-Mann-Straße 40, 53111, Bonn, Germany.
Günter FeickBundesverband Prostatakrebs Selbsthilfe (BPS), Thomas-Mann-Straße 40, 5311, Bonn, Germany.
Simone WesselmannDeutsche Krebsgesellschaft, Kuno-Fischer-Straße 8, 14057, Berlin, Germany.
Bundesverband Glaukom-Selbsthilfe · DEFischer (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since 2016, certified prostate cancer centres have been able to participate in the Prostate Cancer Outcomes (PCO) study. The aim of this study is to compare outcomes across centres after local treatment for prostate cancer. The study originated from a support group initiative and is jointly carried out by the German Cancer Society (Deutsche Krebsgesellschaft), the certification institute OnkoZert, patient support groups and the participating centres. So far, centres have been more successful at recruiting patients undergoing surgery than those receiving radiotherapy as the definitive treatment. This means that conclusions for the latter group of patients are almost impossible. It is important to us that all types of treatment are equally well represented in the study; thus, we encourage radiation therapists to participate in the PCO study.

Indexed as

Cancer Care FacilitiesGermanyHumansMaleProstatic NeoplasmsSocieties, MedicalTreatment OutcomeCertificationHealth Services ResearchPatient Reported Outcome MeasuresQuality ImprovementVariation

Identifiers

PMID32548712
OpenAlexW3034414331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.